News & Updates

Proton pump inhibitors (PPIs) are linked to heightened risk of fractures among older adults with autoimmune rheumatic and gastrointestinal diseases, especially when PPIs are used in conjunction with glucocorticoids, according to a study.

Faecal microbiota transplantation (FMT) with standardized anaerobic cultivated human intestinal microbiome is safe but does not appear to be efficacious in patients with systemic sclerosis experiencing lower gastrointestinal (GI) tract symptoms, according to a phase II study.

Preliminary data from an observational case–control study have shown that selexipag is safe and effective in the treatment of systemic sclerosis vasculopathy, particularly digital ulcers (DUs) and Raynaud phenomenon (RP).

In the treatment of patients with polymyalgia rheumatica, the Janus kinase 1/2 inhibitor baricitinib helps reduce the need to take oral glucocorticoids to have low disease activity while having no new safety signals, according to data from the randomized, double-blind BACHELOR trial.

Weather changes tend to influence the clinical profile of patients with psoriatic arthritis (PsA), reveals a recent study, which examined weather variations through subjective and objective patient-reported outcomes (PROs) matched with those with PsA.

Cardiovascular (CV) events during pregnancy appear to moderately increase the risk of adverse pregnancy outcomes (APOs), such as preterm birth, small for gestational age (SGA), or both, reports a recent study.

In the treatment of patients with moderate-to-severe chronic low back pain, the use of infliximab does not yield meaningful reductions in pain-related disability when compared with placebo, as shown in a study.